Saxony Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Buy
2,303
+113
+5% +$115K 1.27% 21
2026
Q1
$2.01M Buy
2,190
+2
+0.1% +$2.03K 1.17% 22
2025
Q4
$2.35M Sell
2,188
-25
-1% -$23.9K 1.44% 18
2025
Q3
$1.69M Buy
2,213
+40
+2% +$29.8K 1.11% 27
2025
Q2
$1.69M Buy
2,173
+29
+1% +$22.5K 1.3% 29
2025
Q1
$1.77M Sell
2,144
-52
-2% -$43.3K 1.55% 21
2024
Q4
$1.69M Sell
2,196
-90
-4% -$74.5K 1.49% 20
2024
Q3
$2.03M Buy
2,286
+165
+8% +$148K 1.85% 15
2024
Q2
$1.92M Buy
2,121
+297
+16% +$238K 2.11% 9
2024
Q1
$1.42M Buy
1,824
+301
+20% +$214K 1.71% 17
2023
Q4
$888K Buy
+1,523
New +$889K 1.18% 27

Other funds holding LLY

Saxony Capital Management's LLY Position: Q2 2026 in Review

Saxony Capital Management increased its Eli Lilly (LLY) stake by 5.2% in Q2 2026, buying an estimated $115K and bringing the position to 2,303 shares worth $2.76M. The position accounts for 1.27% of the portfolio, ranked #21.

Saxony Capital Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,943 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Saxony Capital Management held 2,303 shares of Eli Lilly worth $2.76M as of Q2 2026.
  • Saxony Capital Management bought 113 Eli Lilly shares in Q2 2026, an estimated $115K.
  • Eli Lilly made up 1.27% of Saxony Capital Management's portfolio in Q2 2026, its #21 holding.
  • Saxony Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,943 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Saxony Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.